MacroGenics reported $38.59M in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Amgen AMGN:US USD 5.06B 20M
AstraZeneca AZN:LN USD 8.86B 3M
Biogen BIIB:US USD 2.04B 66.1M
Bristol Myers Squibb BMY:US USD 8.86B 345M
Daiichi Sankyo 4568:JP JPY 242.71B 37.19B
Eli Lilly And LLY:US USD 5.36B 305M
Gilead Sciences GILD:US USD 5.65B 829M
Johnson & Johnson JNJ:US USD 15.98B 134M
Karyopharm Therapeutics KPTI:US USD 35.16M 3.58M
MacroGenics MGNX:US USD 38.59M 14.99M
Merk MRK:US USD 11.52B 1.08B
Pfizer PFE:US USD 16.55B 2.52B
Regeneron Pharmaceuticals REGN:US USD 2.62B 58.3M
Roche Holding ROG:VX 22.73B 924M
Seattle Genetics SGEN:US USD 402.18M 10.78M